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Abstract
The strict spatio-temporal control of Rho GTPases is critical for many cellular functions, including
cell motility, contractility, and growth. In this regard, the prototypical Rho family GTPases, Rho,
Rac, and Cdc42 regulate the activity of each other by a still poorly understood mechanism. Indeed,
we found that constitutively active forms of Rac inhibit stress fiber formation and Rho stimulation
by thrombin. Surprisingly, a mutant of Rac that is unable to activate Pak1 failed to inhibit thrombin
signaling to Rho. To explore the underlying mechanism, we investigated whether Pak1 could
regulate guanine nucleotide exchange factors (GEFs) for Rho. We found that Pak1 associates with
P115-RhoGEF but not with PDZ-RhoGEF or LARG, and knock down experiments revealed that
P115-RhoGEF plays a major role in signaling from thrombin receptors to Rho in HEK293T cells.
Pak1 binds the DH-PH domain of P115-RhoGEF, thus suggesting a mechanism by which Rac
stimulation of Pak1 may disrupt receptor-dependent Rho signaling. In agreement, expression of a
dominant-negative Pak-Inhibitory Domain potentiated the activation of Rho by thrombin, and
prevented the inhibition of Rho by Rac. These findings indicate that Rac interferes with receptor-
dependent Rho stimulation through Pak1, thus providing a mechanism for cross-talk between these
two small-GTPases.
Background
Rho family GTPases control a wide variety of critical cell
functions that are important in development, immunity,
and disease processes ranging from oncogenesis, hyper-
tension, and asthma. These cell behaviors include migra-
tion, proliferation, contact-inhibition, and contraction
[1]. Proper execution of these cellular processes depends
on the fine spatio-temporal regulation of small GTPases
within a cell. This is achieved by the coordinated regula-
tion of guanidine exchange factors (GEFs), which stimu-
late Rho proteins, and GTPase activating proteins (GAPs)
and GDP dissociation inhibitors (GDIs), that terminate or
inhibit their function [2]. The vast majority of GEFs con-
tain a Dbl-homology (DH) domain, by which they bind
and stabilize small GTPases in a nucleotide-free state, and
use the 10-fold molar excess of intracellular GTP over
GDP to promote their subsequent binding to GTP [2].
GAP proteins, on the other hand, exert a negative regula-
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tion by associating with GTP-bound Rho proteins and
enhancing their GTPase activity. GDIs also inhibit Rho
GTPase activity, by binding inactive GDP-bound proteins,
and stabilizing Rho GTPases in this "off" state [3]. Of
these small GTPase regulators, DH-containing GEF pro-
teins have been the best described mediators of signaling
from cell surface receptors, including G protein coupled
receptors and receptor tyrosine kinases, to the small
GTPases [4].
The changes in overall cell behavior resulting from the
activation of Rho GTPases by GEFs are reflected in a series
of well-described morphological alterations, including
the formation of actin-filled protrusions such as filapodia
and lammellipodia, and the assembly of parallel actin
cables (stress-fibers) [1,5]. Among these cellular struc-
tures, the Rho-dependent formation of stress-fibers has
been implicated in the contractility of cultured fibroblasts
[6]. Motile cells polarize during chemotaxis into leading
and trailing edges that are characterized by Cdc42 and Rac
activity at the leading edge and Rho activity at the retract-
ing end of the cell [7]. The presence of a retracting subcel-
lular compartment playing counterpoint to the
lammellipodia-rich leading edge is a hallmark feature of
the polarized and motile cell. Inhibition of Rho-depend-
ent signals with pharmacological inhibitors or dominant
negative mutants, destroys this polarization, producing
impaired chemotactic responses [7].
Since the initial description of the proto-typical Rho fam-
ily GTPases, Rho, Rac, and Cdc42, it has been recognized
that these molecules regulate each other's activity. In Swiss
3T3 cells, the effects of over-active Rho, Rac, and Cdc42
mutants on actin cytoskeleton morphology suggest a cas-
cade where Cdc42 activates Rac, which in turn activates
Rho [5]. More recent studies using other cell types, how-
ever, have shown that Rho and Rac can have opposing
effects on cell migration and growth cone extension [7-
10]. In line with the latter, we found that Rac prevents Rho
activation and stress fiber formation in response to
thrombin in both endothelial cells and HEK293T cells.
While exploring the underlying mechanism, we observed
that Rac effector domain mutants that do not to bind
Pak1, a Rac effector, fail to inhibit thrombin-induced
stress fiber formation and Rho activation. As thrombin
can stimulate Rho through the α subunits of heterot-
rimeric G proteins of the G12/13 family, we examined
whether Pak1 could interact with members of the RGS-
containing family of Rho GEF, PDZ-RhoGEF, LARG and
P115RhoGEF, which act downstream from Gα12/13
[11,12]. Indeed, we found that Pak1 can bind the DH-PH
domain of P115RhoGEF, thereby forming a molecular
complex in vivo. Furthermore, we provide evidence that
Pak1 may represent a point of signal integration by ena-
bling Rac to inhibit receptor-dependent Rho stimulation.
Results
Rac inhibits thrombin-induced stress fiber formation and 
Rho activation
In order to investigate the interplay between Rho and Rac
signaling, we tested whether thrombin-dependent stress-
fiber formation was sensitive to Rac signaling (Figure 1A).
Incubation of endothelial cells with thrombin showed
striking increases in stress-fibers. These structures
appeared as thick actin cables running along the length of
the cell. Instead, Rac-transfected cells took on an invariant
rounded shape, exhibited high levels of cortical actin, and
did not form stress-fibers upon thrombin stimulation.
These results suggested that Rac signaling strongly affected
the ability of thrombin to stimulate Rho. To investigate
this contention, we asked whether the presence of consti-
tutive Rac signaling modulated the intracellular levels of
Rho bound to GTP. As shown in figure 1B, transfection of
an active form of Rac in HEK293T cells prevented the
accumulation of Rho-GTP in response to thrombin stim-
ulation. Taken together, these data revealed that Rac sign-
aling abrogates thrombin signaling to Rho.
To further examine which signaling pathways down-
stream of Rac might be inhibiting thrombin signaling to
Rho, we took advantage of the availability of activated Rac
mutants harboring additional mutations that restrict their
signaling ability. As shown in figure 2, a RacV12 mutant
missing the insert region of the Rac1-α domain that is
implicated in Rac-dependent activation of reactive oxygen
species (ROS) was nevertheless effective in blocking
stress-fiber formation stimulated by thrombin [13]. By
contrast, RacV12C40, an effector domain mutant of Rac
that does not bind nor activate Pak, was unable to prevent
stress-fiber formation in response to thrombin (Figure
2A) [14]. We confirmed these results with Rho-pulldown
assays to detect relative levels of Rho-GTP after thrombin
stimulation. Both control cells and cells transiently over-
expressing RacV12C40 accumulated similar levels of Rho-
GTP after thrombin stimulation (Figure 2B). However,
both the RacV12 and RacV12Δins mutants prevented
thrombin treatment from increasing Rho-GTP levels, par-
alleling the effects seen with stress-fiber formation.
Pak1 interacts with P115RhoGEF
As RacV12C40 mutant is unable to bind Pak1, we there-
fore focused on whether Pak1 might be involved in Rac
inhibition of thrombin signaling to Rho. Rho activation
stimulated by G12/13  coupled receptors such as the
thrombin receptors has been shown to occur through the
RGS-containing Rho GTP exchange factors, a protein fam-
ily that includes PDZ-RhoGEF, LARG, and P115RhoGEF
[12,14,15]. Interestingly, in a recent study we have
observed that Pak4, but not Pak1 and Pak2, inhibits the
functional activity of PDZ-RhoGEF upon binding to its C-
terminal regulatory region [16]. Based on this observa-Journal of Molecular Signaling 2006, 1:8 http://www.jmolecularsignaling.com/content/1/1/8
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tion, we investigated whether there was a physical interac-
tion between RGS-containing RhoGEFs and Pak1. As
shown in figure 3A, P115RhoGEF, but not PDZ-RhoGEF
or LARG, co-immunoprecipitated with Pak1, and this
interaction was enhanced by the presence of activated Rac.
Molecular association between Pak1 and P115RhoGEF
could also be detected when P115RhoGEF was immuno-
precipitated (Figure 3B). Moreover, immunoprecipitated
full length P115RhoGEF was efficiently phosphorylated
by Pak1 (Figure 3C).
To assess the contribution of P115RhoGEF in thrombin
signaling to Rho, we used siRNA oligonucleotides to
knockdown P115RhoGEF in HEK293T cells (Figure 3D).
Depletion of P115RhoGEF in these cells greatly impaired
Rho activation in the presence of thrombin. Although
P115RhoGEF knockdown decreased total Rho levels
slightly, quantitation of ECL exposures from these experi-
ments using NIH Image™ showed that P115RhoGEF
knockdown inhibited >60% of Rho-GTP accumulation in
response to thrombin treatment. To further define the
interaction between P115RhoGEF, we used a set of
P115RhoGEF deletion constructs to determine where
Pak1 binds (Figure 4A). Co-immunoprecipitation experi-
ments with these mutants revealed that deletion of the
P115RhoGEF N-terminus greatly facilitated binding to
Pak1 (Figure 4B). By contrast, deletion of the C-terminus
produced a protein that was still regulated by Rac. The C-
Activated Rac inhibits thrombin signaling to Rho Figure 1
Activated Rac inhibits thrombin signaling to Rho. (A) PAE cells transfected with pCEFL-GFP as a control or with the activated 
RacV12 mutant and pCEFL-GFP together (RacV12) were starved overnight on poly-D-lysine coated glass cover-slips, treated 
with thrombin 5 U/ml for indicated times, fixed, and stained with TRITC-phalloidin. Arrows point to transfected cells as judged 
by co-transfection with pCEFL-GFP. (B) HEK293T cells were transfected with pCEFL-GFP as a control or with the activated 
RacV12 mutant and pCEFL-GFP together with RacV12 (RacV12), cultured overnight, starved for 4 h, and treated with 
thrombin for indicated times. Fresh lysates were used for Rho-pulldown assays with GST-Rhotekin to detect relative amounts 
of Rho-GTP. Total Rho levels were detected by western blot in total cell lysates as a loading control.
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terminal region, which has previously been described as a
site of protein-protein interaction in RGS GEFs, was by
itself unable to bind Pak1. These results narrowed down
the region of interaction between Pak1 and P115RhoGEF
to a region between amino acids 351 and 771. Interest-
ingly, these residues form the DH and PH domains of
P115RhoGEF. To directly test whether Pak1 could bind
this motif, we asked whether Pak1 could bind the DH-PH
domain of P115RhoGEF, as well as the isolated DH-PH
domains of PDZ-RhoGEF and LARG. Of these three pro-
teins, only the DH-PH domain of P115RhoGEF was able
to bind Pak1 (Figure 4C)
Rac requires Pak1 for Rho Inhibition in vivo
We next challenged the notion that Pak1 function is nec-
essary for Rac-mediated inhibition of Rho. In resting,
unstimulated, cells Pak1 exists as a homodimer in which
each binding partner inhibits the kinase domain of the
other [17]. The region of Pak1 that binds and inhibits the
kinase domain has been isolated. This Pak1 inhibitory
domain (PID) can be used to block Pak1 activity and the
biological effects of Pak1 signaling, such as the dissocia-
tion of Rac from RhoGDI [18,19], GPCR-dependent cell
transformation and estrogen-dependent transcription in
breast cancer cells [20,21]. Indeed, transfection with this
Activated Rac requires Pak1 binding for inhibition of thrombin signaling to Rho Figure 2
Activated Rac requires Pak1 binding for inhibition of thrombin signaling to Rho. (A) PAE cells transfected with pCEFL-GFP as a 
control or with RacV12, RacV12C40, RacV12Δins mutants together with pCEFL-GFP as indicated were starved overnight on 
poly-D-lysine coated glass cover-slips, placed in serum-free media (control) or treated with thrombin (5 U/ml) 30 min, fixed 
and stained with TRITC-labelled phalloidin. Transfected cells were detected by GFP flourescence. (B) HEK293T cells were 
transfected with pCEFL-GFP as a control or with the RacV12 mutants shown in (A) together with pCEFL-GFP, cultured over-
night, starved 4 h, treated with thrombin (5 U/ml) for 1 min, and lysed. Fresh lysates were used for Rho-pulldown assays with 
GST-Rhotekin to detect relative amounts of Rho-GTP. Total Rho levels were detected by western blot in total cell lysates as a 
loading control.
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PID domain dramatically increased the Rho response to
thrombin (Figure 5A). Importantly, expression of the
Pak1 PID domain reversed the ability of Rac signaling to
inhibit thrombin activation of Rho (Figure 5B). These
data strongly implicated Pak1 as a mediator of Rac inhibi-
tion of thrombin signaling to Rho.
Pak1 binds and phosphorylates P115RhoGEF Figure 3
Pak1 binds and phosphorylates P115RhoGEF. (A) HEK293T cells were transfected with expression plasmids encoding GFP, 
GFP-PDZ-RhoGEF (PRG), GFP-P115RhoGEF (P115), or GFP-LARG (LARG) in the presence or absence of wild-type myc 
tagged Pak1 and/or the activated Rac mutant RacQL (Rac). Lysates were immunoprecipitated with anti-myc antibody, and 
immunoprecipitates tested for GEF content by western blotting with anti-GFP antibody. (B) HEK293T cells were transfected 
with expression plasmids encoding GFP, GFP-GFP-P115RhoGEF (P115) in the presence or absence of wild-type myc tagged 
Pak1 and/or the activated Rac mutant RacV12 (Rac). Lysates were incubated with anti-AU1 antibody, and immunoprecipitates 
tested for Pak1 content by western blotting with anti-Pak1 antibody. (C) HEK293T cells were transfected with AU1-tagged full 
length P115RhoGEF. Two days post-transfection, cells were harvested in lysis buffer. Lysates were incubated with anti-AU1 
antibody and immunoprecipitates were placed in kinase buffer containing recombinant Pak1 and γ-32P-ATP for times indicated. 
Kinase reactions were stopped with the addition of sample buffer and boiling. Samples were resolved by SDS-PAGE and acryla-
mide gels were transferred to PVDF membranes. Resulting blots were exposed to X-ray film 24 h to detect phosphorylated 
proteins. Total immunoprecipitated P115RhoGEF levels were assessed by coomassie staining. (D) HEK293T cells were trans-
fected with control or P115RhoGEF-specific siRNA oligonucleotides, and treated with thrombin for times indicated. Fresh 
lysates were used for Rho-pulldown assays with GST-Rhotekin to detect relative amounts of Rho-GTP. Total Rho levels were 
detected by western blot in total cell lysates as a loading control.
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Discussion
The Rac and Rho GTPases have opposing effects in many
cell types, including endothelial, smooth muscle, and
neuronal cells, and can override signals from each other
depending on cell type [8-10,22]. In this study, we show
that the ability of thrombin to promote stress fiber forma-
tion and stimulate Rho can be inhibited by activated
forms of Rac. In search for the underlying mechanism, we
found that Rac effector domain mutants that cannot inter-
act with Pak1 fail to block thrombin signaling to Rho.
Indeed, inhibition of Pak by a Pak-inhibitory construct
enhanced the extent of Rho activation after thrombin
treatment, and prevented co-transfected Rac from block-
ing the increase in Rho-GTP levels. Furthermore, we pro-
vide evidence that Rac promotes the formation of a
molecular complex between Pak1 and P115RhoGEF in
vivo, a signaling molecule that is required for the bulk of
thrombin signaling to Rho, thus providing a likely mech-
anism by which Rac can restrict Rho activation.
Recent reports have implicated Pak family kinases in the
regulation of Rho GEFs. In particular, a two hybrid screen
Pak1 binds the DH-PH domain of P115RhoGEF Figure 4
Pak1 binds the DH-PH domain of P115RhoGEF. (A) Constructs used in these experiments. (B) HEK293T cells were trans-
fected with expression plasmids encoding the AU1-tagged constructs shown in (A) in the presence or absence of wild-type 
myc-tagged Pak1 and/or the activated Rac mutant RacQL (Rac). Lysates were immunoprecipitated with anti-myc antibody, and 
immunoprecipitates tested for GEF content by western blotting with anti-AU1 antibody. (C) HEK293T cells were transfected 
with expression plasmids encoding AU1-tagged DH-PH domains of P115RhoGEF (P115), PDZ-RhoGEF (PRG), and LARG 
(LARG) in the presence or absence of wild-type myc tagged Pak1 and/or the activated Rac mutant RacQL (Rac). The 
P115RhoGEF ΔN construct is included as a control. Lysates were immunoprecipitated with anti-myc antibody, and immuno-
precipitates tested for GEF content by western blotting with anti-AU1 antibody.
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approach for molecules binding the C-terminal regulatory
domain of PDZ-RhoGEF identified Pak4, a Cdc42 effector
that is member of the class II Pak family as a binding part-
ner [16,23]. Similarly, GEF-H1, a microtubule-localized
Rho Exchange Factor, binds Pak1 at its C-terminus, and
GEF-H1 a substrate for this kinase [24]. Moreover, acti-
vated Cdc42 can stimulate Pak1 phosphorylation of GEF-
H1 in vitro, suggesting a possible role for Pak1 in the reg-
ulation of GEF-H1 downstream of cellular receptors.
Recently, Alberts and colleagues reported the inhibitory
phosphorylation of NET1 just outside its DH-PH domain,
by Pak1 [25]. Thus, although we cannot rule out that Rac
may regulate RhoGDIs or RhoGAPs through Pak1 thereby
inhibiting Rho activation by thrombin, our findings sug-
gest that this inhibitory effect of Rac can be exerted
through the binding of Pak1 to P115RhoGEF.
The precise mechanism by which Pak1 regulates
P115RhoGEF function is at the present unknown.
Although Pak1 can bind the isolated DH-PH domain of
P115RhoGEF, Pak1 does not phosphorylate this domain
when expressed and purified from E. coli in in vitro kinase
Pak1 inhibitory domain (PID) reverts Rac inhibition of Rho by Rac Figure 5
Pak1 inhibitory domain (PID) reverts Rac inhibition of Rho by Rac. (A) HEK293T cells were transfected with plasmids express-
ing a GFP or GFP-PID fusion protein (PID) (1 μg/plate) and incubated for two days, serum-starved 4 h, and treated with 
thrombin (5 U/ml) for times indicated. Fresh lysates were used for Rho-pulldown assays with GST-Rhotekin to detect relative 
amounts of Rho-GTP. Total Rho levels were detected by western blot in total cell lysates as a loading control. GFP western 
blot from total cell lysate was used to detect the GFP-PID fusion protein. (A) Cells were co-transfected with plasmids encoding 
the active RacV12 (Rac) mutant in the presence of control pCEFL-GFP or pCEFL-GFP-PID (2 μg/plate). After 2 days incubation 
cells were serum-starved 4 h, stimulated with thrombin (5 U/ml, 2 min), and assayed for Rho-GTP levels with pulldown assays. 
Data are expressed as fold increase ± SEM in Rho-GTP with respect to unstimulated control cells.
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assays, nor does the binding of Pak1 affect the in vitro
GTP-exchange activity of p115RhoGEF on RhoA (not
shown). Similarly, we did not observe changes in the in
vitro Rho GEF activity of P115RhoGEF when its different
deletion constructs were expressed together with Pak1 in
293T cells (not shown), which is aligned with the accu-
mulating evidence that suggests that the in vitro activity of
RGS-containing Rho GEFs does not reflect fully their
likely complex regulation in vivo. For example, these Rho
GEFs are poorly activated in vitro by Gα12, in spite of the
strong evidence that Gα12 interacts and activates the GEF
activity of this class of Rho GEFs in vivo [26,27]. Similarly,
the removal of the potent inhibitory activity exerted by the
C-terminal region of p115RhoGEF, PDZ-RhoGEF, and
LARG in vivo does not result in the enhanced ability of
these GEFs to stimulate nucleotide exchange on Rho in
vitro [28]. Thus, it is possible that additional molecules
may participate in the regulation of P115RhoGEF by Pak1
in vivo, or that Pak1 may interfere with the targeting of
p115RhoGEF by activated G12/13 to a particular subcellu-
lar fraction or membrane microdomain, whose functional
consequences would not be reflected by the GEF activity
of p115RhoGEF in vitro.
On the other hand, the finding that Pak1 binds the DH-
PH domain of P115RhoGEF may have important regula-
tory consequences upon G protein-link receptor activa-
tion. Previous studies have shown that the RGS domain of
P115RhoGEF regulates the DH-PH catalytic activity [26].
In this model, the RGS domain of P115RhoGEF binds the
DH-PH domain intramolecularly, thus hindering steri-
cally its ability to interact with Rho proteins. Pak1 binding
to full-length P115RhoGEF is stimulated by the presence
of active Rac1, suggesting that activation of Pak1 by Rac
enhances the interaction between Pak1 and P115RhoGEF.
However, this regulation is abrogated when the N-termi-
nal 351 amino acids of P115RhoGEF, that include the
RGS domain, are deleted. Furthermore, the isolated DH-
PH domain of P115RhoGEF binds Pak1 constitutively in
vivo. This may reflect what is likely to occur upon ligand-
induced activation of P115RhoGEF. In this scenario, stim-
ulation of GPCRs, such as thrombin receptors, activates
Gα12/13 subunits which will then bind the RGS domain of
P115RhoGEF de-repressing and exposing its DH-PH
domain, thereby stimulating Rho proteins [27]. This
exposed DH-PH domain can then be more accessible for
its interaction and inactivation by Pak1, if Rac is concom-
itantly activated. Indeed, many receptors are coupled to
both the G12/13 and Gi pathways; therefore it is possible
that the same receptor may activate Rho through G12/13
and Rac through Gi, the latter regulating the temporal and
spatial activation of Rho.
In this regard, although the underlying mechanisms of
crosstalk between signaling from cellular receptors remain
elusive, there is a growing literature describing the interac-
tions between G12/13 and Gi signaling systems and the
necessity for this co-regulation in the proper execution of
cell behaviors such as cell migration and neurite extension
[7]. For example, the bacterial peptide formyl-methionyl-
leucine-phenylalanine (fMLP) is a strong chemoattractant
for neutrophils [29]. This molecule binds a Gi coupled
receptor, and activates Gi-dependent pathways such as
Rac, PI-3-Kinase, and AKT in neutrophils and cells that
resemble this cell-type such as differentiated HL-60 cells
[30,31]. However, Xu et al. have recently shown that fMLP
also stimulates Rho in these cells, and that pertussis toxin
treatment fails to inhibit this Rho activation, while totally
shutting down signaling to Rac [7]. Thus, the fMLP recep-
tor is coupled to both G12/13 and Gi in HL60 cells. These
findings lead to a model in which a single receptor uses
dual Gi and G12/13 coupling to create a polarized migrating
cell. Crosstalk between G12/13 and Gi can also occur when
multiple receptor subtypes exhibiting distinct coupling
ability are activated by their ligand, such as those for lyso-
phosphatidic acid (LPA) and sphingosine-1-phosphate
(S1P) that are preferentially coupled to Gi, G12/G13 and Gi,
or Gq [32], and can be also activated indirectly by other
cell surface receptors, such as receptor tyrosine kinases
[33,34]. These examples of G12/13 and Gi co-regulation of
the same cell behavior highlight the necessity of these two
pathways to modulate each other, and Pak1/
P115RhoGEF complex formation may provide such a
link.
Conclusion
The finding that Rac regulates the association of Pak1 with
P115-RhoGEF may represent a potential mechanism of
cross-talk among Rho GTPases, in which the effector of
one Rho GTPase regulates the function of a GEF for
another small GTP-binding protein. Indeed, this appears
to be an emerging theme in cell biology, as documented
by recent studies demonstrating the de-repression of
p190RhoGAP by a ROS-mediated mechanisms stimu-
lated by the persistent and prolonged expression of active
Rac, the negative regulation of Rac-mediated ROS forma-
tion by Cdc42, the interaction between Pak4 and PDZ-
RhoGEF, and the interaction between Pak1 and GEF-H1
and NET1 [16,22,24,25,35]. Considering the importance
of the proper coordination of Rho GTPase function for
many key developmental and physiological processes [4],
we can expect that the full elucidation of the mechanism
underpinning the coordinated activation/inactivation of
Rho GTPases may ultimately help explain how the dysreg-
ulated activity of Rho proteins can contribute to human
diseases.Journal of Molecular Signaling 2006, 1:8 http://www.jmolecularsignaling.com/content/1/1/8
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Methods
Materials
Bovine serum albumin (fatty acid-free) Dulbecco's modi-
fied Eagle's medium (DMEM), trypsin/EDTA solution,
and Fetal bovine serum (FBS) were purchased from Sigma
(St. Louis, Mo); anti-mouse secondary HRP-linked anti-
body was from ICN pharmaceuticals (Aurora, Ohio); and
Glutathione-sepharose beads were purchased from Amer-
sham Biosciences (Piscataway, NJ). Anti-GFP, AU5, and
AU1 antibodies were purchased from Covance (Prince-
ton, NJ). The Anti-Rac1 antibody was purchased from BD
Transduction Laboratories (Franklin Lakes, NJ).
DNA constructs
pCMV6M-Pak1 was kindly provided by J. Field [36].
pCEFL-AU1-P115RhoGEF and deletion constructs were
subcloned as previously described [28]. The RacQ61L,
RacG12V, RacG12V, Y40C mutants were generated using PCR-
based mutagenesis (Stratagene, La Jolla, CA) and sub-
cloned into pCEFL-AU5. The RacV12Δ ins mutant was con-
structed by deleting amino acids 124–135 which
comprise the insert region of Rac by using an overlapping
primer extension approach [37]. The Pak1 inhibitory
domain encoding amino acids 67–147 of Pak1 was
amplified by PCR and subcloned into pCEFL-GFP. The
P115RhoGEF DH-PH sequence encoding amino acids
351–771 was transferred as BglII/NotI fragments into
pGEX-4T3 generating the pGEX-P115RhoGEF DH-PH
clone that was expressed in E. coli.
Immunohistochemistry
Porcine airway endothelial (PAE) cells were grown in 6-
well plates on coverslips and co-transfected with pCEFL-
EGFP and pCEFL-AU5-Rac constructs. Cells were serum
starved for 16 hours and then stimulated with thrombin
(5 U/ml) (Sigma-Aldrich, Inc; St. Louis, MO), washed
twice with phosphate buffered saline (PBS), fixed with
3.7% paraformaldehyde in PBS and then permeabilized
with PBS containing 0.5% Triton X-100. Following 30
minutes incubation in PBS containing 1% BSA, cells were
stained with TRITC-phalloidin (Invitrogen Molecular
Probes, Carlsbad, CA) following the manufacturer's
instructions. Coverslips were mounted using Vectashield
mounting medium for fluorescence (Vector Laboratories,
Burlingame, CA) and visualized using Axioplan2 micro-
scope (Carl Zeiss MicroImaging, Inc, Thornwood, NY).
GFP and TRITC fluorescence was detected using Chroma
Technology (Rockingham, VT) filter sets and 41001 and
41002B, respectively.
Transfection, Immunoprecipitations and Western blotting
Human embryonic kidney 293T (HEK293T) cells were
maintained in Dulbecco's modified Eagle's medium sup-
plemented with 10% fetal bovine serum. Porcine airway
endothelial (PAE) cells were cultured in F12 media con-
taining 10% fetal bovine serum. Transfections were per-
formed in 60 mm or 100-mm cell culture dishes using
LipofectAMINE Plus™ reagent (Invitrogen, Carlsbad, CA)
according to the manufacturer's protocol. The total
amount of DNA was adjusted to 3 μg/plate with pCEFL-
EGFP when necessary. Transfection of siRNA oligonucle-
otides was achieved using the Hyperfect™ reagent (Qia-
gen, Valencia, CA) according to the manufacturer's
instructions. The P115RhoGEF sense and antisense siRNA
oligonucleotides were r(GCA GCU CUG AGA ACG GCA
A)dTdT and r(UUG CCG UUC UCA GAG CUG C)dTdG,
respectively. Sense and antisense negative control siRNA
oligonucleotides were r(UUC UCC GAA CGU GUC ACG
U)dT dT and r(ACG UGA CAC GUU CGG AGA A)dT dT,
respectively. Immunoprecipitations and Western blotting
were performed as previously described [38].
Rho-pulldown Assays
Cytosolic extracts were prepared from HEK293T cells
transfected with vector or expression plasmids. Rho-pull-
down assays using a GST-Rhotekin fusion protein were
performed essentially as previously reported [39].
Kinase Assays
Pak1 autophosphorylating, MBP phosphorylating and
P115RhoGEF DH-PH phosphorylating kinase activity was
assessed in vitro, essentially as described previously for
extracellular signal-regulated kinase assays with a different
kinase buffer (12.5 mM MOPS, pH 7.5, 1 mM beta-glycer-
ophosphate, 10 mM MgCl2, 3 mM MnCl2, 0.5 mM NaF,
0.5 mM ortho-vanadate, 0.5 mM EGTA, 3 mM DTT, 20
μM ATP, 250 μCi/ml ATP γ32P) [40].
Nucleotide Exchange Assays
Rho GTP exchange reactions to measure the catalytic activ-
ity of the P115RhoGEF DH-PH were performed in 1×
Kinase buffer supplemented with GTPγS and recombinant
His-Rho (12.5 mM MOPS, pH 7.5, 1 mM beta-glycero-
phosphate, 10 mM MgCl2, 3 mM MnCl2, 0.5 mM NaF, 0.5
mM ortho-vanadate, 0.5 mM EGTA, 3 mM DTT, 20 μM
ATP, 4 μM GTPγS, 2 μCi/ml GTPγ35S 1 μM His-Rho) in a
final volume of 70 μl. At t = 0 1 1 μM of GST-P115RhoGEF
DH-PH +/- 0.5–3 μM GST-Pak1 was added to experimen-
tal samples and tubes were moved to 30°C water bath.
After each time point, 10 μl from each reaction was added
to 2 ml cold wash solution (100 mM Tris, pH 7.5, 20 mM
NaCl, 1 mM MgCl2, 0.5 mM DTT, 1 mg/ml BSA). Each
sample was vacuum filtered over nitrocellulose and rinsed
4× with 2 ml wash solution. Filters were placed in 20 ml
scintillation fluid (Cytoscint, ICN) and 35S activity was
determined in a Beckman LSC 6000C Scintillation coun-
ter.
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